Search research articles
Contact Us
Filters
Showing results (11-20 of 119) with videos related to
Page
of 12
Sort By:
Diabetes Technology & Therapeutics
|
June 15, 2011
Evolution of devices in diabetes management
Alfred Penfornis, Estelle Personeni, Sophie Borot
Diabetes Technology & Therapeutics
|
July 25, 2025
Long-Term Patterns in Automated Insulin Delivery and Carbohydrate Announcement: A 24-Month Follow-Up
Estelle Godard, Alfred Penfornis, Coralie Amadou
Annales D'Endocrinologie
|
November 6, 2012
LDL-cholesterol target values and actual values in patients with type 2 diabetes (T2D) uncontrolled on oral antidiabetic monotherapy: the lipid results of the French ESCALADE survey
Alfred Penfornis, Alain Baleydier, Thierry Clavel, et al.
Human Immunology
|
January 1, 2003
Polymorphisms of human TAP2 detected by denaturing gradient gel electrophoresis
Alfred Penfornis, Gang Yan, Lijia Shi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 24, 2002
Impaired processing and presentation by MHC class II proteins in human diabetic cells
Gang Yan, Lijia Shi, Alfred Penfornis, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
July 15, 2015
Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
Alfred Penfornis, Béatrice Fiquet, Jean Frédéric Blicklé, et al.
Journal of Diabetes Science and Technology
|
May 31, 2014
Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based Study
Udo Stauder, Diplom Enginee, Hina Elton, et al.
Surgery
|
February 16, 2010
Results of cryopreserved parathyroid autografts: a retrospective multicenter study
Sophie Borot, Valérie Lapierre, Bruno Carnaille, et al.
Patient Preference and Adherence
|
May 17, 2018
Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement
Francesco Giorgino, Alfred Penfornis, Valeria Pechtner, et al.
Diabetes & Metabolism
|
October 19, 2021
Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch
Coralie Amadou, Sylvia Franc, Erik Huneker, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 119) with videos related to
Sort By:
Page
of 12
Diabetes Technology & Therapeutics
|
June 15, 2011
Evolution of devices in diabetes management
Alfred Penfornis, Estelle Personeni, Sophie Borot
Diabetes Technology & Therapeutics
|
July 25, 2025
Long-Term Patterns in Automated Insulin Delivery and Carbohydrate Announcement: A 24-Month Follow-Up
Estelle Godard, Alfred Penfornis, Coralie Amadou
Annales D'Endocrinologie
|
November 6, 2012
LDL-cholesterol target values and actual values in patients with type 2 diabetes (T2D) uncontrolled on oral antidiabetic monotherapy: the lipid results of the French ESCALADE survey
Alfred Penfornis, Alain Baleydier, Thierry Clavel, et al.
Human Immunology
|
January 1, 2003
Polymorphisms of human TAP2 detected by denaturing gradient gel electrophoresis
Alfred Penfornis, Gang Yan, Lijia Shi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 24, 2002
Impaired processing and presentation by MHC class II proteins in human diabetic cells
Gang Yan, Lijia Shi, Alfred Penfornis, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
July 15, 2015
Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
Alfred Penfornis, Béatrice Fiquet, Jean Frédéric Blicklé, et al.
Journal of Diabetes Science and Technology
|
May 31, 2014
Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based Study
Udo Stauder, Diplom Enginee, Hina Elton, et al.
Surgery
|
February 16, 2010
Results of cryopreserved parathyroid autografts: a retrospective multicenter study
Sophie Borot, Valérie Lapierre, Bruno Carnaille, et al.
Patient Preference and Adherence
|
May 17, 2018
Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement
Francesco Giorgino, Alfred Penfornis, Valeria Pechtner, et al.
Diabetes & Metabolism
|
October 19, 2021
Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch
Coralie Amadou, Sylvia Franc, Erik Huneker, et al.
Page
of 12